Eric Stavale

1.2k total citations
16 papers, 676 citations indexed

About

Eric Stavale is a scholar working on Infectious Diseases, Public Health, Environmental and Occupational Health and Epidemiology. According to data from OpenAlex, Eric Stavale has authored 16 papers receiving a total of 676 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 7 papers in Public Health, Environmental and Occupational Health and 5 papers in Epidemiology. Recurrent topics in Eric Stavale's work include Viral Infections and Outbreaks Research (7 papers), Mosquito-borne diseases and control (7 papers) and Viral Infections and Vectors (5 papers). Eric Stavale is often cited by papers focused on Viral Infections and Outbreaks Research (7 papers), Mosquito-borne diseases and control (7 papers) and Viral Infections and Vectors (5 papers). Eric Stavale collaborates with scholars based in United States, Canada and Mali. Eric Stavale's co-authors include Kelly L. Warfield, Urban Ramstedt, M. Javad Aman, Kevin F. Jones, Robert Jordan, Dongcheng Dai, Christine A. Schneider, Aklile Berhanu, Chelsea M. Byrd and Jessica Pagé and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Scientific Reports.

In The Last Decade

Eric Stavale

16 papers receiving 641 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eric Stavale United States	12	397	367	133	121	82	16	676
Irina C. Albulescu Netherlands	14	522 1.3×	460 1.3×	122 0.9×	165 1.4×	102 1.2×	20	840
Marianne Lucas‐Hourani France	12	354 0.9×	317 0.9×	210 1.6×	186 1.5×	84 1.0×	15	682
Mee Kian Poh Singapore	6	305 0.8×	359 1.0×	120 0.9×	123 1.0×	94 1.1×	6	592
Rubén Soto-Acosta United States	8	290 0.7×	326 0.9×	106 0.8×	125 1.0×	37 0.5×	12	549
Wolfgang Fischl Germany	9	401 1.0×	549 1.5×	167 1.3×	210 1.7×	126 1.5×	10	906
Chinmay G. Patkar United States	11	355 0.9×	446 1.2×	62 0.5×	68 0.6×	106 1.3×	11	593
Sudip Khadka United States	7	310 0.8×	365 1.0×	159 1.2×	252 2.1×	131 1.6×	15	829
Megan Pavy Australia	8	328 0.8×	360 1.0×	88 0.7×	77 0.6×	68 0.8×	12	548
Diego Allonso Brazil	14	256 0.6×	348 0.9×	77 0.6×	101 0.8×	32 0.4×	30	559
Arun S. Annamalai United States	13	330 0.8×	183 0.5×	160 1.2×	146 1.2×	244 3.0×	19	615

Countries citing papers authored by Eric Stavale

Since Specialization

Citations

This map shows the geographic impact of Eric Stavale's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Stavale with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Stavale more than expected).

Fields of papers citing papers by Eric Stavale

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric Stavale. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Stavale. The network helps show where Eric Stavale may publish in the future.

Co-authorship network of co-authors of Eric Stavale

This figure shows the co-authorship network connecting the top 25 collaborators of Eric Stavale. A scholar is included among the top collaborators of Eric Stavale based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric Stavale. Eric Stavale is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Stavale, Eric, et al.. (2023). Developing Vaccines to Improve Preparedness for Filovirus Outbreaks: The Perspective of the USA Biomedical Advanced Research and Development Authority (BARDA). Vaccines. 11(6). 1120–1120. 11 indexed citations

Comer, Jason E., Trevor Brasel, Shane Massey, et al.. (2022). Natural History of Marburg Virus Infection to Support Medical Countermeasure Development. Viruses. 14(10). 2291–2291. 9 indexed citations

Warfield, Kelly L., Lisa Evans DeWald, Kevin B. Spurgers, et al.. (2019). Lack of selective resistance of influenza A virus in presence of host-targeted antiviral, UV-4B. Scientific Reports. 9(1). 7484–7484. 31 indexed citations

Logue, James, Dean Follmann, Greg Grandits, et al.. (2018). Use of the Filovirus Animal Non-Clinical Group (FANG) Ebola virus immuno-assay requires fewer study participants to power a study than the Alpha Diagnostic International assay. Journal of Virological Methods. 255. 84–90. 18 indexed citations

Billioux, Bridgette Jeanne, Avindra Nath, Eric Stavale, et al.. (2017). Cerebrospinal Fluid Examination in Survivors of Ebola Virus Disease. JAMA Neurology. 74(9). 1141–1141. 13 indexed citations

Pettitt, James, Elizabeth S. Higgs, Mosoka Fallah, et al.. (2016). Assessment and Optimization of the GeneXpert Diagnostic Platform for Detection of Ebola Virus RNA in Seminal Fluid. The Journal of Infectious Diseases. 215(4). jiw599–jiw599. 10 indexed citations

Stavale, Eric, Hong Vu, Aruna Sampath, Urban Ramstedt, & Kelly L. Warfield. (2015). In Vivo Therapeutic Protection against Influenza A (H1N1) Oseltamivir-Sensitive and Resistant Viruses by the Iminosugar UV-4. PLoS ONE. 10(3). e0121662–e0121662. 26 indexed citations

Warfield, Kelly L., Emily M. Plummer, Dominic S. Alonzi, et al.. (2015). A Novel Iminosugar UV-12 with Activity against the Diverse Viruses Influenza and Dengue (Novel Iminosugar Antiviral for Influenza and Dengue). Viruses. 7(5). 2404–2427. 26 indexed citations

Sully, Erin K., Kevin J. Whaley, Natasha Bohorova, et al.. (2014). A tripartite cocktail of chimeric monoclonal antibodies passively protects mice against ricin, staphylococcal enterotoxin B and Clostridium perfringens epsilon toxin. Toxicon. 92. 36–41. 10 indexed citations

10.

Carocci, Margot, Stephen M. Hinshaw, Mary A. Rodgers, et al.. (2014). The Bioactive Lipid 4-Hydroxyphenyl Retinamide Inhibits Flavivirus Replication. Antimicrobial Agents and Chemotherapy. 59(1). 85–95. 48 indexed citations

11.

Byrd, Chelsea M., Douglas W. Grosenbach, Aklile Berhanu, et al.. (2013). Novel Benzoxazole Inhibitor of Dengue Virus Replication That Targets the NS3 Helicase. Antimicrobial Agents and Chemotherapy. 57(4). 1902–1912. 82 indexed citations

12.

Perry, Stuart T., Michael D. Buck, Emily M. Plummer, et al.. (2013). An iminosugar with potent inhibition of dengue virus infection in vivo. Antiviral Research. 98(1). 35–43. 86 indexed citations

13.

Karaüzüm, Hatice, Gang Chen, Laura Abaandou, et al.. (2012). Synthetic Human Monoclonal Antibodies toward Staphylococcal Enterotoxin B (SEB) Protective against Toxic Shock Syndrome. Journal of Biological Chemistry. 287(30). 25203–25215. 51 indexed citations

14.

Byrd, Chelsea M., Dongcheng Dai, Douglas W. Grosenbach, et al.. (2012). A Novel Inhibitor of Dengue Virus Replication That Targets the Capsid Protein. Antimicrobial Agents and Chemotherapy. 57(1). 15–25. 136 indexed citations

15.

Kehn‐Hall, Kylene, Aarthi Narayanan, Lindsay Lundberg, et al.. (2012). Modulation of GSK-3β Activity in Venezuelan Equine Encephalitis Virus Infection. PLoS ONE. 7(4). e34761–e34761. 44 indexed citations

16.

Aman, M. Javad, Michael S. Kinch, Kelly L. Warfield, et al.. (2009). Development of a broad-spectrum antiviral with activity against Ebola virus. Antiviral Research. 83(3). 245–251. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact